{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:16:43Z","timestamp":1773497803225,"version":"3.50.1"},"reference-count":74,"publisher":"National Institute for Health and Care Research","issue":"31","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/50\/49"],"award-info":[{"award-number":["10\/50\/49"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Most patients with oesophageal cancer present with incurable disease. For those with advanced disease, the mean survival is 3\u20135 months. Treatment emphasis is therefore on effective palliation, with the majority of patients requiring intervention for dysphagia. Insertion of a self-expanding metal stent provides rapid relief but dysphagia may recur within 3 months owing to tumour progression. Evidence reviews have called for trials of interventions combined with stenting to better maintain the ability to swallow.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n The Radiotherapy after Oesophageal Cancer Stenting (ROCS) study examined the effectiveness of palliative radiotherapy, combined with insertion of a stent, in maintaining the ability to swallow. The trial also examined the impact that the ability to swallow had on quality of life, bleeding events, survival and cost-effectiveness.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A pragmatic, multicentre, randomised controlled trial with follow-up every 4 weeks for 12 months. An embedded qualitative study examined trial experiences in a participant subgroup.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Participants were recruited in secondary care, with all planned follow-up at home.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Patients who were referred for stent insertion as the primary management of dysphagia related to incurable oesophageal cancer.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Following stent insertion, the external beam radiotherapy arm received palliative oesophageal radiotherapy at a dose of 20\u2009Gy in five fractions or 30\u2009Gy in 10 fractions.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n The primary outcome was the difference in the proportion of participants with recurrent dysphagia, or death, at 12 weeks. Recurrent dysphagia was defined as deterioration of \u2265\u200911 points on the dysphagia scale of the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire oesophago-gastric module questionnaire. Secondary outcomes included quality of life, bleeding risk and survival.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study recruited 220 patients: 112 were randomised to the usual-care arm and 108 were randomised to the external beam radiotherapy arm. There was no evidence that radiotherapy reduced recurrence of dysphagia at 12 weeks (48.6% in the usual-care arm compared with 45.3% in the external beam radiotherapy arm; adjusted odds ratio 0.82, 95% confidence interval 0.40 to 1.68; p<\/jats:italic>\u2009=\u20090.587) and it was less cost-effective than stent insertion alone. There was no difference in median survival or key quality-of-life outcomes. There were fewer bleeding events in the external beam radiotherapy arm. Exploration of patient experience prompted changes to trial processes. Participants in both trial arms experienced difficulty in managing the physical and psychosocial aspects of eating restriction and uncertainties of living with advanced oesophageal cancer.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Change in timing of the primary outcome to 12 weeks may affect the ability to detect a true intervention effect. However, consistency of results across sensitivity analyses is robust, including secondary analysis of dysphagia deterioration-free survival.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Widely accessible palliative external beam radiotherapy in combination with stent insertion does not reduce the risk of dysphagia recurrence at 12 weeks, does not have an impact on survival and is less cost-effective than inserting a stent alone. Reductions in bleeding events should be considered in the context of patient-described trade-offs of fatigue and burdens of attending hospital. Trial design elements including at-home data capture, regular multicentre nurse meetings and qualitative enquiry improved recruitment\/data capture, and should be considered for future studies.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n Further studies are required to identify interventions that improve stent efficacy and to address the multidimensional challenges of eating and nutrition in this patient population.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN12376468 and Clinicaltrials.gov NCT01915693.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 25, No. 31. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta25310","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:31:14Z","timestamp":1622118674000},"page":"1-144","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT"],"prefix":"10.3310","volume":"25","clinical-trial-number":[{"clinical-trial-number":"isrctn12376468","registry":"10.18810\/isrctn","type":"results"},{"clinical-trial-number":"nct01915693","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-1593","authenticated-orcid":true,"given":"Douglas","family":"Adamson","sequence":"first","affiliation":[{"name":"Tayside Cancer Centre, Ninewells Hospital, NHS Tayside, Dundee, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-3330","authenticated-orcid":true,"given":"Jane","family":"Blazeby","sequence":"additional","affiliation":[{"name":"Bristol Centre for Surgical Research, NIHR Bristol and Weston Biomedical Research Centre, Bristol University, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-0677","authenticated-orcid":true,"given":"Catharine","family":"Porter","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-8355","authenticated-orcid":true,"given":"Christopher","family":"Hurt","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-8021","authenticated-orcid":true,"given":"Gareth","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Southampton Clinical Trials Unit, University of Southampton, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6075-8425","authenticated-orcid":true,"given":"Annmarie","family":"Nelson","sequence":"additional","affiliation":[{"name":"Marie Curie Research Centre, Division of Population Medicine, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5471-922X","authenticated-orcid":true,"given":"Bernadette","family":"Sewell","sequence":"additional","affiliation":[{"name":"Swansea Centre for Health Economics, Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9661-4899","authenticated-orcid":true,"given":"Mari","family":"Jones","sequence":"additional","affiliation":[{"name":"Swansea Centre for Health Economics, Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-4039","authenticated-orcid":true,"given":"Martina","family":"Svobodova","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-8410","authenticated-orcid":true,"given":"Deborah","family":"Fitzsimmons","sequence":"additional","affiliation":[{"name":"Swansea Centre for Health Economics, Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-6970","authenticated-orcid":true,"given":"Lisette","family":"Nixon","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-8510","authenticated-orcid":true,"given":"Jim","family":"Fitzgibbon","sequence":"additional","affiliation":[{"name":"Lay research partners, Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1824-8448","authenticated-orcid":true,"given":"Stephen","family":"Thomas","sequence":"additional","affiliation":[{"name":"Lay research partners, Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-8779","authenticated-orcid":true,"given":"Anthony","family":"Millin","sequence":"additional","affiliation":[{"name":"Velindre University NHS Trust, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-1756","authenticated-orcid":true,"given":"Tom","family":"Crosby","sequence":"additional","affiliation":[{"name":"Velindre University NHS Trust, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-3172","authenticated-orcid":true,"given":"John","family":"Staffurth","sequence":"additional","affiliation":[{"name":"Velindre University NHS Trust, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-1496","authenticated-orcid":true,"given":"Anthony","family":"Byrne","sequence":"additional","affiliation":[{"name":"Marie Curie Research Centre, Division of Population Medicine, Cardiff University, Cardiff, UK"},{"name":"Velindre University NHS Trust, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2021,5]]},"reference":[{"key":"key20210521161426217_ref1-bib1","volume-title":"Oesophageal Cancer Statistics","author":"Cancer Research UK"},{"key":"key20210521161426217_ref1-bib2","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1038\/s41598-018-19819-8","article-title":"Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep"},{"key":"key20210521161426217_ref1-bib3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0002-9610(97)00104-9","article-title":"Outcome, survival, and costs in patients undergoing intubation for carcinoma of the oesophagus","volume":"174","author":"O\u2019Hanlon","year":"1997","journal-title":"Am J Surg"},{"key":"key20210521161426217_ref1-bib4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1148\/radiology.195.3.7538682","article-title":"Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses","volume":"195","author":"Watkinson","year":"1995","journal-title":"Radiology"},{"key":"key20210521161426217_ref1-bib5","unstructured":"Scottish Audit of Gastric and Oesophageal Cancer. Report 1997\u20132000: A Prospective Audit. Edinburgh: Scottish Audit of Gastric and Oesophageal Cancer Steering Group; 2002."},{"issue":"5","key":"key20210521161426217_ref1-bib6","doi-asserted-by":"publisher","DOI":"10.3310\/hta9050","article-title":"A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer","volume":"9","author":"Shenfine","year":"2005","journal-title":"Health Technol Assess"},{"key":"key20210521161426217_ref1-bib7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/ajg.2009.155","article-title":"A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer","volume":"104","author":"Shenfine","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key20210521161426217_ref1-bib8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005048.pub2","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"4","author":"Sreedharan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20210521161426217_ref1-bib9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005048.pub4","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"10","author":"Dai","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key20210521161426217_ref1-bib10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"key20210521161426217_ref1-bib11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","article-title":"Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial","volume":"18","author":"Bergquist","year":"2005","journal-title":"Dis Esophagus"},{"key":"key20210521161426217_ref1-bib12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.radonc.2010.09.001","article-title":"Adding external beam radiotherapy to intraluminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomised trial of the International Atomic Energy Agency","volume":"97","author":"Rosenblatt","year":"2010","journal-title":"Radiother Oncol"},{"key":"key20210521161426217_ref1-bib13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.gie.2012.04.442","article-title":"Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophogeal cancer","volume":"76","author":"Hirdes","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"key20210521161426217_ref1-bib14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.radonc.2013.04.008","article-title":"Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial","volume":"107","author":"Amdal","year":"2013","journal-title":"Radiother Oncol"},{"key":"key20210521161426217_ref1-bib15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S1470-2045(14)70131-7","article-title":"Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial","volume":"15","author":"Zhu","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20210521161426217_ref1-bib16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12957-016-0768-x","article-title":"Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma","volume":"14","author":"Tian","year":"2016","journal-title":"World J Surg Oncol"},{"key":"key20210521161426217_ref1-bib17","unstructured":"Healthcare Quality Improvement Partnership Ltd (HQP). An Audit of the Care Received by People with Oesophago-Gastric Cancer in England and Wales 2017 Annual Report. London: HQP; 2017."},{"key":"key20210521161426217_ref1-bib18","unstructured":"Royal College of Radiologists. The Role and Development of Brachytherapy Services in the United Kingdom. London: Royal College of Radiologists; 2007."},{"key":"key20210521161426217_ref1-bib19","unstructured":"Healthcare Quality Improvement Partnership Ltd (HQP). An Audit of the Care Received by People with Oesophago-Gastric Cancer in England and Wales 2013 Annual Report. London: HQP; 2013."},{"key":"key20210521161426217_ref1-bib20","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1111\/j.1572-0241.2007.01565.x","article-title":"A randomised prospective comparison of self-expandable metal stents in the palliation of malignant esophageal dysphagia","volume":"102","author":"Conio","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key20210521161426217_ref1-bib21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1572-0241.2007.01542.x","article-title":"New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial","volume":"103","author":"Verschuur","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20210521161426217_ref1-bib22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/1475-6773.01113","article-title":"Medical expenditures during the last year of life: findings from the 1992-1996 Medicare Current Beneficiary Survey","volume":"37","author":"Hoover","year":"2002","journal-title":"Health Serv Res"},{"key":"key20210521161426217_ref1-bib23","volume-title":"Use of Health and Social Care by People with Cancer","author":"Chitris","year":"2014"},{"key":"key20210521161426217_ref1-bib24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12029-010-9206-4","article-title":"Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial","volume":"43","author":"Javed","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"key20210521161426217_ref1-bib25","volume-title":"Radiotherapy Dose Fractionation","author":"Royal College of Radiologists","year":"2017","edition":"2"},{"key":"key20210521161426217_ref1-bib26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1745-6215-15-402","article-title":"Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): protocol for a randomised controlled trial","volume":"15","author":"Adamson","year":"2014","journal-title":"Trials"},{"key":"key20210521161426217_ref1-bib27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.bjc.6601146","article-title":"Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer","volume":"89","author":"Blazeby","year":"2003","journal-title":"Br J Cancer"},{"key":"key20210521161426217_ref1-bib28","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ejca.2007.07.005","article-title":"Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach","volume":"43","author":"Lagergren","year":"2007","journal-title":"Eur J Cancer"},{"key":"key20210521161426217_ref1-bib29","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0959-8049(03)00270-3","article-title":"Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer","volume":"39","author":"Blazeby","year":"2003","journal-title":"Eur J Cancer"},{"key":"key20210521161426217_ref1-bib30","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.ejca.2004.05.023","article-title":"Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer","volume":"40","author":"Blazeby","year":"2004","journal-title":"Eur J Cancer"},{"key":"key20210521161426217_ref1-bib31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20210521161426217_ref1-bib32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.37.4.505","article-title":"Quality of life measurement in patients with oesophageal cancer","volume":"37","author":"Blazeby","year":"1995","journal-title":"Gut"},{"key":"key20210521161426217_ref1-bib33","unstructured":"National Institute for Health and Care Excellence (NICE). Methods for Technology Appraisals. London: NICE; 2009."},{"key":"key20210521161426217_ref1-bib34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol: a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"key20210521161426217_ref1-bib35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"key20210521161426217_ref1-bib36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/MCG.0000000000000333","article-title":"Randomized trial of small-diameter versus large-diameter esophageal stents for palliation of malignant esophageal obstruction","volume":"49","author":"White","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"key20210521161426217_ref1-bib37","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.ijsu.2010.09.006","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials","volume":"4","author":"Schulz","year":"2010","journal-title":"Open Med"},{"key":"key20210521161426217_ref1-bib38","volume-title":"The EORTC QLQ-C30 Scoring Manual","author":"European Organisation for Research and Treatment of Cancer"},{"key":"key20210521161426217_ref1-bib39","unstructured":"Cancer Research UK. Beating Cancer Sooner. Our Research Strategy. London: Cancer Research UK; 2014."},{"key":"key20210521161426217_ref1-bib40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2702.2006.01412.x","article-title":"Patients\u2019 experiences of living with oesophageal cancer","volume":"15","author":"Andreassen","year":"2006","journal-title":"J Clin Nurs"},{"key":"key20210521161426217_ref1-bib41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.11124\/JBISRIR-2016-003168","article-title":"Patient, nursing and medical staff experiences and perceptions of the care of people with palliative esophagogastric cancer: a systematic review of the qualitative evidence","volume":"14","author":"Cowley","year":"2016","journal-title":"JBI Database System Rev Implement Rep"},{"key":"key20210521161426217_ref1-bib42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1359105310368448","article-title":"The role of identity in adjustment among survivors of oesophageal cancer","volume":"16","author":"Clarke","year":"2011","journal-title":"J Health Psychol"},{"key":"key20210521161426217_ref1-bib43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejon.2010.10.006","article-title":"Living with incurable oesophageal cancer. A phenomenological hermeneutical interpretation of patient stories","volume":"15","author":"Missel","year":"2011","journal-title":"Eur J Oncol Nurs"},{"key":"key20210521161426217_ref1-bib44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2354.2003.00376.x","article-title":"The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer","volume":"12","author":"Watt","year":"2003","journal-title":"Eur J Cancer Care"},{"key":"key20210521161426217_ref1-bib45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10388-019-00665-0","article-title":"Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma","volume":"16","author":"Kakuta","year":"2019","journal-title":"Esophagus"},{"key":"key20210521161426217_ref1-bib46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"key20210521161426217_ref1-bib47","first-page":"270","article-title":"Expandable metal stents in the palliation of malignant dysphagia and oesophageal respiratory fistula","volume":"94","author":"McGrath","year":"2001","journal-title":"Ir Med J"},{"key":"key20210521161426217_ref1-bib48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0720-048X(02)00154-7","article-title":"Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center\u2019s experience with four different stents","volume":"43","author":"Rozanes","year":"2002","journal-title":"Eur J Radiol"},{"key":"key20210521161426217_ref1-bib49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1442-2050.2008.00906.x","article-title":"Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life","volume":"22","author":"Madhusudhan","year":"2009","journal-title":"Dis Esophagus"},{"key":"key20210521161426217_ref1-bib50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/cdn\/nzz030.P05-031-19","article-title":"Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: a randomized control trial (P05-031-19)","volume":"3","author":"Qiu","year":"2019","journal-title":"Curr Dev Nutr"},{"key":"key20210521161426217_ref1-bib51","volume-title":"WHO Definition of Palliative Care","author":"World Health Organization"},{"key":"key20210521161426217_ref1-bib52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12904-019-0445-2","article-title":"Table in the Corner: a qualitative study of life situation and perspectives of the everyday lives of oesophageal cancer patients in palliative care","volume":"18","author":"Laursen","year":"2019","journal-title":"BMC Palliat Care"},{"key":"key20210521161426217_ref1-bib53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/bmjspcare-2013-000551","article-title":"The practice of palliative care from the perspective of patients and carers","volume":"4","author":"Sampson","year":"2014","journal-title":"BMJ Support Palliat Care"},{"key":"key20210521161426217_ref1-bib54","volume-title":"Equity in the Provision of Palliative Care in the UK: Review of Evidence","author":"Dixon","year":"2015"},{"key":"key20210521161426217_ref1-bib55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-684X-13-22","article-title":"\u2018It\u2019s alright to ask for help\u2019: findings from a qualitative study exploring the information and support needs for family carers at the end of life","volume":"13","author":"Harrop","year":"2014","journal-title":"BMC Palliat Care"},{"key":"key20210521161426217_ref1-bib56","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1365-2702.2008.02405.x","article-title":"A systematic review of informal caregivers\u2019 needs in providing home-based end-of-life care to people with cancer","volume":"18","author":"Bee","year":"2009","journal-title":"J Clin Nurs"},{"key":"key20210521161426217_ref1-bib57","unstructured":"National Institute for Health and Care Excellence (NICE). Developing NICE Guidelines: the Manual. Process and Methods [PMG20]. London: NICE; 2017. URL: www.nice.org.uk\/process\/pmg20\/chapter\/introduction-and-overview (accessed 19 July 2019)."},{"key":"key20210521161426217_ref1-bib58","volume-title":"CCEMG-EPPI-Centre Cost Converter","year":"2019"},{"key":"key20210521161426217_ref1-bib59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"PharmacoEconomics"},{"key":"key20210521161426217_ref1-bib60","unstructured":"Department of Health and Social Care (DHSC). NHS Reference Costs 2017 to 2018. London: DHSC; 2018. URL: https:\/\/improvement.nhs.uk\/resources\/reference-costs\/ (accessed 20 October 2019)."},{"key":"key20210521161426217_ref1-bib61","volume-title":"Client Service Receipt Inventory","author":"Beecham","year":"1997"},{"key":"key20210521161426217_ref1-bib62","volume-title":"Unit Costs of Health and Social Care 2018","author":"Curtis","year":"2018"},{"key":"key20210521161426217_ref1-bib63","volume-title":"British National Formulary","author":"Joint Formulary Committee"},{"key":"key20210521161426217_ref1-bib64","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3233\/NRE-130893","article-title":"A less conservative method to adjust for familywise error rate in neuropsychological research: the Holm\u2019s sequential Bonferroni procedure","volume":"32","author":"Eichstaedt","year":"2013","journal-title":"NeuroRehabil"},{"key":"key20210521161426217_ref1-bib65","unstructured":"National Institute for Health and Care Excellence (NICE). Costing Statement: Blood Transfusion. London: NICE; 2015. URL: www.nice.org.uk\/guidance\/ng24\/resources\/costing-statement-2177158141 (accessed 18 October 2019)."},{"key":"key20210521161426217_ref1-bib66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/082585971102700208","article-title":"Comparing the costs of alternative models of end-of-life care","volume":"27","author":"McBride","year":"2011","journal-title":"J Palliat Care"},{"key":"key20210521161426217_ref1-bib67","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key20210521161426217_ref1-bib68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1442-2050.2008.00916.x","article-title":"Economic analysis of esophageal stenting for management of malignant dysphagia","volume":"22","author":"Rao","year":"2009","journal-title":"Dis Esophagus"},{"key":"key20210521161426217_ref1-bib69","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s10620-008-0302-2","article-title":"Cost-effectiveness of palliation of unresectable esophageal cancer","volume":"53","author":"da Silveira","year":"2008","journal-title":"Dig Dis Sci"},{"key":"key20210521161426217_ref1-bib70","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1057\/jors.2010.20","article-title":"Applications of simulation within the healthcare context","volume":"62","author":"Katsaliaki","year":"2011","journal-title":"J Oper Res"},{"key":"key20210521161426217_ref1-bib71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","article-title":"Rates and probabilities in economic modelling","volume":"25","author":"Fleurence","year":"2007","journal-title":"PharmacoEconomics"},{"key":"key20210521161426217_ref1-bib72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12885-018-4620-2","article-title":"Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study","volume":"18","author":"Thein","year":"2018","journal-title":"BMC Cancer"},{"key":"key20210521161426217_ref1-bib73","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/bjs.7599","article-title":"Healthcare resource use and medical costs for the management of oesophageal cancer","volume":"98","author":"Gordon","year":"2011","journal-title":"Br J Surg"},{"key":"key20210521161426217_ref1-bib74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2036708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta25310\/hta25310.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2036708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:38:12Z","timestamp":1692113892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta25310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":74,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["10.3310\/hta25310"],"URL":"https:\/\/doi.org\/10.3310\/hta25310","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"3-2013","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"11-2019","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"6-2020","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}